The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

Stopped Could not enroll subjects who met the stringent inclusion/exclusion criteria.

Conditions

• Peripheral Arterial Disease

Interventions

• DRUG: Dipyridamole 200mg and Aspirin 25mg bid:
• DRUG: Dipyridamole 200 mg bid
• DRUG: Aspirin 25 mg bid

Sponsor

University of Pennsylvania

Collaborators

• [object Object]